Rigel Pharmaceuticals | Kısa Vadeli Yükümlülükler





Kısa Vadeli Yükümlülükler Değişiklik Tarih
Agenus USD 287.13M 52.57M 2025-09
Amgen USD 25.49B 3.7B 2025-12
Anika Therapeutics USD 19.09M 3.01M 2025-09
Arrowhead Research USD 347.42M 151.94M 2025-12
AstraZeneca USD 30.62B 3.44B 2025-12
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Celldex Therapeutics USD 46.46M 13.5M 2025-09
Daiichi Sankyo JPY 778.55B 77.51B 2025-12
Eli Lilly USD 40.14B 1.12B 2025-09
Halozyme Therapeutics USD 837.23M 702.95M 2025-09
Heron Therapeutics USD 89.71M 168.89M 2025-09
Intrexon USD 23.02M 38K 2024-06
Ionis Pharmaceuticals USD 903.46M 6.22M 2025-09
Karyopharm Therapeutics USD 87.16M 12.06M 2025-09
Ligand Pharmaceuticals USD 30.54M 34.2M 2025-09
MacroGenics USD 44.47M 5.47M 2025-09
Neurocrine Biosciences USD 638M 91.7M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Veracyte USD 72.15M 4.28M 2025-09


Rigel Pharmaceuticals Kısa Vadeli Yükümlülükler - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Feb 2026.